← Back to graph
Supplement

citicoline CDP-choline low dose

Selected indexed studies

  • SCARLET (Supplemental Citicoline Administration to Reduce Lung injury Efficacy Trial): study protocol for a single-site, double-blinded, placebo-controlled, and randomized Phase 1/2 trial of i.v. citicoline (CDP-choline) in hospitalized SARS CoV-2-infected patients with hypoxemic acute respiratory failure. (Trials, 2024) [PMID:38760804]
  • Regenerative Effects of CDP-Choline: A Dose-Dependent Study in the Toxic Cuprizone Model of De- and Remyelination. (Pharmaceuticals (Basel), 2021) [PMID:34832936]
  • The acute dose and baseline amplitude-dependent effects of CDP-choline on deviance detection (MMN) in chronic schizophrenia: A pilot study. (Exp Clin Psychopharmacol, 2022) [PMID:33630646]

_Worker-drafted node — pending editorial review._

Connections

citicoline CDP-choline low dose helps

citicoline CDP-choline low dose protects against

Sources

Local graph